The Marked Chart Wire · Business
Earnings
Rapport Therapeutics surges on bipolar trial success; Vicor and MSCI beat earnings
Rapport Therapeutics shares jump 28 percent after a bipolar drug trial meets its goals. Vicor and MSCI report strong third-quarter results, while FreightCar America drops 19 percent after cutting its outlook.
